Results 161 to 170 of about 762,599 (262)
Summary diagram for the role of CypA in chemoresistance in non‐small cell lung cancer (NSCLC). CypA is overexpressed in chemoresistance NSCLC and drives therapeutic evasion by competitively binding to the K37 site of SLC7A11, thereby blocking TRIM3 mediated K11‐linked ubiquitination and proteasomal degradation, ultimately inhibiting lipid peroxidation ...
Zhongcheng Wang +9 more
wiley +1 more source
Hereditary diffuse gastric cancer: a case report. [PDF]
Li L, An Y, Wang Y.
europepmc +1 more source
Microbiota‐derived quinolinic acid is used as an alternative source of replenishing the intracellular NAD+ pool induced by SIRT3 deficiency to regulate intestinal epithelial cell and T cell function, which has implications for targeting intestinal epithelial cells as an approach to the treatment of immune‐associated diseases, including colorectal ...
Ruiying Niu +12 more
wiley +1 more source
[Retracted] Clinical significance and effect of Sam68 expression in gastric cancer. [PDF]
Xiao J +8 more
europepmc +1 more source
Multiomic profiling of HER2‐low breast cancer identifies three proteomic subtypes with distinct therapeutic strategies: endocrine, antiangiogenic, and anti‐HER2 therapies. Genomic and lactate modification landscapes are detailed, providing insights for precise management.
Shouping Xu +20 more
wiley +1 more source
Epstein-Barr Virus Silences GSDME and Pyroptosis in Gastric Cancer. [PDF]
Lee MH, Lee JY, Kim JY, An YR, Lee SK.
europepmc +1 more source
The Research Progress of Matrix Metalloproteinases in Invasion and Metastasis of Gastric Cancer
亚立 熊
openalex +1 more source
Functional, Pharmacogenomic, and Immune Landscapes of Long Non‐Coding RNAs in Cancer
A systematic analysis of 33 cancer types reveals widespread associations between lncRNAs and cancer pathways, drug responses, immune features, and immunotherapy outcomes. The study identifies key lncRNAs linked to therapeutic response and adverse events and introduces PILNC, an interactive web portal for exploring the functional, pharmacogenomic, and ...
Runhao Wang +15 more
wiley +1 more source
Potential of Adora2b as an immunotherapeutic target for gastric cancer. [PDF]
Li J, Shi R, Zhang X, Guo Z, Ji R.
europepmc +1 more source

